Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2005
11/01/2005US6960450 Antigen activating method and antigen activator
11/01/2005US6960449 Class characterization of circulating cancer cells isolated from body fluids and methods of use
11/01/2005US6960448 Methods for diabetes susceptibility assessment in asymptomatic patients
11/01/2005US6960447 Isolation of membrane bound ligand-specific complexes
11/01/2005US6960445 Determination of endometrial receptivity toward embryo implantation
11/01/2005US6960443 Anticancer, antitumor agents; monoclonal antibodies; genetic engineered protein
11/01/2005US6960442 Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)
11/01/2005US6960441 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and infections; for use as cosmetic, pesticide and antibiotic
11/01/2005US6960440 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/01/2005US6960439 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
11/01/2005US6960430 Screening methods for compounds useful in the regulation of cell proliferation
11/01/2005US6960429 Inhibition of viral gene activities
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
11/01/2005US6960323 preferably a positively charged porous matrix having a negatively charged urea derivative dye on its surface; may further include a peroxide producing signal producing system, e.g., an analyte oxidase and/or peroxidase
11/01/2005US6960298 Mesoporous permeation layers for use on active electronic matrix devices
11/01/2005US6960287 Underfill detection system for a test sensor
11/01/2005US6959590 Emission sampling apparatus and method
11/01/2005US6959588 Couette device and method to study solids deposition from flowing fluids
11/01/2005CA2442066C Pd-1, a receptor for b7-4, and uses therefor
11/01/2005CA2294078C C-peptide specific assay procedure
11/01/2005CA2216125C Method for diagnosis of epstein-barr virus associated disease
11/01/2005CA2163426C Method and apparatus for desorption and ionization of analytes
10/2005
10/30/2005CA2500629A1 Method for determining properties of formation fluids
10/30/2005CA2465655A1 Method for determining glycemic responses of foods
10/29/2005CA2501422A1 Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
10/28/2005CA2505655A1 Stable, water-soluble quantum dot, method of preparation and conjugates thereof
10/28/2005CA2465427A1 Direct assay of cholesterol in skin samples removed by tape stripping
10/27/2005WO2005101278A1 Drug-metabolizing enzyme prediction apparatus
10/27/2005WO2005101230A1 Sytems and methods for improving livestock production
10/27/2005WO2005101023A1 Method and system for drug screening
10/27/2005WO2005101022A2 Diagnostics and therapeutics for diseases associated with vitamin d (1,25-dihydroxyvitamin d3) receptor 1 (vdr1)
10/27/2005WO2005101021A1 Diagnostics and therapeutics for diseases associated with g protein-coupled adrenergic alpha-1d-receptor (adra1d)
10/27/2005WO2005101020A1 Method for analyzing n-terminal protein adducts
10/27/2005WO2005101019A2 Detection of nitrosylated proteins
10/27/2005WO2005101018A1 Immunohistochemical detection method of collagen in a tissue sample
10/27/2005WO2005101017A1 Mass spectrometry of antibody conjugates
10/27/2005WO2005101016A2 Analysis of structure stabilities of diseases-causing proteins and their mutants
10/27/2005WO2005101015A1 Efficient method of functional analysis screening for protein utilizing fluorescence generated in cell-free protein synthesizing system
10/27/2005WO2005101014A2 Diagnostic and therapeutic use of kcnc1 for neurodegenerative diseases
10/27/2005WO2005101013A2 Materials and methods for screening modulators of neural regneration
10/27/2005WO2005101012A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor, familiy c, group 5, member b (gprc5b)
10/27/2005WO2005101011A2 Diagnostics and therapeutics for diseases associated with lxr-alpha (lxra)
10/27/2005WO2005101010A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor gamma (pparg)
10/27/2005WO2005101009A2 Diagnostics and therapeutics for diseases associated with tachykinin receptor 2 (tacr2)
10/27/2005WO2005101008A1 Diagnostics and therapeutics for diseases associated with retinoid x receptor gamma (rxrg)
10/27/2005WO2005101007A1 Diagnostics and therapeutics for diseases associated with liver x receptor beta (lxrb)
10/27/2005WO2005101006A2 Diagnostics and therapeutics for diseases associated with retinoid x receptor beta (rxrb)
10/27/2005WO2005101005A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 32 (gpr32)
10/27/2005WO2005101004A2 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1)
10/27/2005WO2005101003A1 Diagnostics and therapeutics for diseases associated with purinoceptor 4 type y (p2y4)
10/27/2005WO2005101002A1 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 2 (ccr2)
10/27/2005WO2005101001A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor, family c, group 5, member c (gprc5c)
10/27/2005WO2005101000A2 Human glycoprotein hormone superagonists and uses thereof
10/27/2005WO2005100999A2 Functional immunohistochemical cell cycle analysis as a prognostic indicator for cancer
10/27/2005WO2005100997A2 Diagnostics and therapeutics for diseases associated with tachykinin receptor 3 (tacr3)
10/27/2005WO2005100996A1 Diagnostics and therapeutics for diseases associated with purinoceptor 5 type y (p2y5)
10/27/2005WO2005100995A2 Methods of determining allergen response using microarray imminoassay techinques
10/27/2005WO2005100994A1 Partially oxidised macroporous silicon comprising discontinuous silicon walls
10/27/2005WO2005100993A2 Smart combinatorial operando spectroscopy catalytic system
10/27/2005WO2005100992A1 Mtehod of examining disease with cerebral dysfunction, protein marker to be used therein, diagnostic agent and diagnostic kit
10/27/2005WO2005100991A2 Method for detecting dioxin-like compounds
10/27/2005WO2005100990A2 Diagnostics and therapeutics for diseases associated with purinoceptor 2 type y (p2y2)
10/27/2005WO2005100989A2 Hepatotoxicity molecular models
10/27/2005WO2005100988A1 Test piece for analysis
10/27/2005WO2005100987A1 Novel ligand of g protein coupled receptor protein and use thereof
10/27/2005WO2005100986A1 Diagnostics and therapeutics for diseases associated with tachykinin receptor 1(tacr1)
10/27/2005WO2005100985A2 Multiple sorter monitor and control subsystem for flow cytometer
10/27/2005WO2005100984A1 Method of separating and concentrating protein and conditioning sample
10/27/2005WO2005100983A1 Method of examining malignant tumor
10/27/2005WO2005100982A2 Methods for stabilizing 5-azacytidine in plasma
10/27/2005WO2005100981A1 Non-covalent immobilization of indicator molecules
10/27/2005WO2005100979A1 Reference control containing a nucleated red blood cell component
10/27/2005WO2005100973A1 Method of protein analysis
10/27/2005WO2005100972A1 Identification and sorting out of contaminations in conveyed flows of material
10/27/2005WO2005100968A1 Analyzer
10/27/2005WO2005100952A1 Method and system for determining the mass density and dimensional characteristics of an object, and use thereof for controlling nuclear fuel pellets during the production of the same
10/27/2005WO2005100757A1 Motion engine
10/27/2005WO2005100605A1 Orphan receptor tyrosine kinase as a target in breast cancer
10/27/2005WO2005100604A2 Methods for identifying risk of osteoarthritis and treatments thereof
10/27/2005WO2005100603A2 Tape stripping methods for analysis of skin disease and pathological skin state
10/27/2005WO2005100601A2 L-sign polymorphisms and methods involving use of same
10/27/2005WO2005100593A1 A method for monitoring the progress of cancer
10/27/2005WO2005100592A1 A pharmacologic method of lowering cholesterol production
10/27/2005WO2005100591A1 Method of assaying cholesterol of high-density lipoprotein
10/27/2005WO2005100590A2 Cell display libraries
10/27/2005WO2005100589A2 Kinetic process for the detection, diagnosis, processing, and monitoring of clonal cell populations
10/27/2005WO2005100588A2 Protein-protein interactions for pharmacological profiling
10/27/2005WO2005100567A1 Gene encoding guanine nucleotide exchange factor and its gene product
10/27/2005WO2005100566A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
10/27/2005WO2005100553A2 Method for assessment of cytotoxic lymphocyte activity
10/27/2005WO2005100545A1 Dual-transfected cells lines as in vitro screening tools for pharmaceutical compound profiling: a model for heptobiliary elimination
10/27/2005WO2005100537A1 Device and method for studying cell migration and deformation
10/27/2005WO2005100405A2 Phosphorylcholine conjugates and corresponding antibodies
10/27/2005WO2005100404A1 Prostate cancer diagnosis and treatment
10/27/2005WO2005100403A2 Antibodies to erythropoietin receptor and uses thereof
10/27/2005WO2005100401A2 Monoclonal antibodies with specificity for fetal erythroid cells
10/27/2005WO2005100398A1 Method of preparing antibody library
10/27/2005WO2005100396A1 Diagnostics and therapeutics for diseases associated with retinoid x receptor alpha (rxra)
10/27/2005WO2005100391A1 Diagnosis of inflammatory bowel diseases, more particularly ulcerative colitis
10/27/2005WO2005100385A2 Compounds that block the c5a receptor and their use in therapy
1 ... 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 ... 3937